Sartorius Stedim Biotech S.A. buy Barclays PLC
Start price
06.01.26
/
50%
€218.80
Target price
06.01.27
-
Performance (%)
-20.02%
Price
09:16
€175.00
Summary
This prediction is currently active. The price of Sartorius Stedim Biotech S.A. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.02%. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sartorius Stedim Biotech S.A. | -6.855% | -6.855% |
| iShares Core DAX® | 1.001% | -1.218% |
| iShares Nasdaq 100 | -1.447% | -4.597% |
| iShares Nikkei 225® | 8.406% | 8.425% |
| iShares S&P 500 | -0.226% | -2.451% |
Comments by Barclays_PLC for this prediction
In the thread Sartorius Stedim Biotech S.A. diskutieren
Sartorius Stedim Biotech (OTCMKTS:SDMHF) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for SDMHF provided by MarketBeat